WALTER KLEMP V. - CEO and President, Director at Moleculin Biotech, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director
Issuer Symbol
MBRX on Nasdaq
All Insider Reports
All Insider Reports

WALTER KLEMP V. - trading volume in the past year for Moleculin Biotech, Inc.

Holdings reported by WALTER KLEMP V. for Moleculin Biotech, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Performance Based Restricted Stock Units 3,960,731 $1,327,119 $3.57 12 Nov 2025 Direct Common Stock
Restricted Stock Units 2,380,731 $1,171,503 $3.57 04 Nov 2025 Direct Common Stock
Common Stock 765,356 $380,381 $0.4970 04 Nov 2025 Direct
Stock option (right to buy) 3,210,731 12 Nov 2025 Direct Common Stock
Series E Warrants 2,409,481 23 Jun 2025 Direct Common Stock

Transactions reported by WALTER KLEMP V. for Moleculin Biotech, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.